Manuel Hidalgo Medina is Director at Guardant Health, Inc. (GH). They have made 7 open-market trades across 1 company since 2025, most recently 2026-10-17.
CIK 0001865525
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GH | 5,252 | $886K |
Shares reported on the most recent Form 4, priced at the 2026-10-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GH | SELL | 2026-08-05 | 2026-08-06 | $164.24 | $279K | -1.1% | -0.5% | +4.2% |
| GH | SELL | 2026-05-28 | 2026-05-29 | $130.06 | $130K | +2.4% | +20.5% | +32.0% |
| GH | SELL | 2026-05-20 | 2026-05-22 | $107.09 | $134K | +11.8% | +8.3% | +41.1% |
| GH | SELL | 2026-03-06 | 2026-03-09 | $91.54 | $119K | -2.9% | +1.2% | +36.1% |
| GH | SELL | 2025-12-08 | 2025-12-10 | $105.00 | $131K | -2.9% | +5.6% | -13.3% |
| GH | SELL | 2025-11-07 | 2025-11-10 | $95.19 | $143K | +3.6% | +6.0% | +8.8% |
| GH | SELL | 2025-09-12 | 2025-09-15 | $54.16 | $235K | +10.2% | +17.5% | +87.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.